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Followmg infectron by the malaria parasite, human erythrocytes show Increased uptake of a wide variety of low molecular weight solutes via 
pathways with functtonal characteristics dtfferent from those of the transporters of normal erythrocytes. In this study glibenclamrde and meghtinide 
were shown to inhibit the induced transport of a sugar alcohol (sorbitol). an amino acid (threonine). an Inorganic anion (Cl-) and an organic cation 
(choline) into human erythrocytes infected in vitro with PIusrrlod~un~fulcipururr~. The results are consistent wrth the hypothesis that a diverse range 
of substrates enter malana-Infected cells via common pathways which have features in common with Cl- channels in other cell types. Ghbenclamide 
and meglitimde were also shown to Inhibit the m vitro growth of the mtracellular parasite which would suggest that these pathways may be a viable 
chemotherapeutic target. 
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1. INTRODUCTION 
The sulfonyl urea glibenclamide and the structurally 
related compounds meglitinide and tolbutamide stimu- 
late the release of insulin from pancreatic p-cells and 
have been used in the treatment of diabetes. Their hypo- 
glycaemia-inducing action has been attributed to inhibi- 
tion of ATP-sensitive K+ (K’-ATP) channels in the p- 
cell plasma membrane and they also inhibit K’-ATP 
channels in other cell-types [ 1,2]. Amongst cation-selec- 
tive channels glibenclamide and its various analogues 
appear to be fairly specific for K’-ATP channels. How- 
ever glibenclamide was shown some years ago to inhibit 
Cl- conductance in rabbit kidney [3] and more recently 
it has been identified as a potent inhibitor of chloride 
currents through CFTR (the cystic fibrosis transmem- 
brane conductance regulator), a CAMP-activated Cl- 
channel, mutations in which cause the disease cystic 
fibrosis [4]. 
Following infection by the malaria parasite, human 
erythrocytes show increased permeability to a wide vari- 
ety of low molecular weight solutes (reviewed in [5-71). 
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Abbreviutlons, CFTR. cystic fibrosis transmembrane conductance 
regulator; DIDS, 4.4’-diisothiocyanatostilbene-2.2’-disulfomc actd; 
DMSO, dimethyl sulfoxide; HEPES. N-[2-hydroxyethyllptperazme- 
N’-[2-ethanesulfonic acid]; NPPB. 5-nitro-7-(3-phenylpropylammo) 
benzoic acid. 
The increased permeability is mediated by pathways 
with characteristics unlike those of the transporters of 
normal erythrocytes but showing functional similarities 
to chloride channels in other cell-types [8]. As expected 
for channels, and in contrast to conventional carriers 
[9,10], the parasite-induced pathways show no tendency 
to saturate with increasing substrate concentration (up 
to millimolar levels) and do not discriminate between 
stereoisomers. They are anion-selective with a high per- 
meability to Cl-, and, like Cl- channels elsewhere [ll] 
they have a significant permeability to cations, the mag- 
nitude of which depends on the nature of the counter- 
anion present (Kirk, K., Elford, B.C., Horner. H.A., 
Ellory, J.C. and Newbold, C.I., submitted). The path- 
ways are inhibited by the anion channel blockers nif- 
lumate, furosemide and 5-nitro-2-(3_phenylpropyla- 
mino) benzoic acid (NPPB) [8], and the IC,, value for 
inhibition of malaria-induced choline transport by 
NPPB falls within the range of those reported previ- 
ously for Cl- channels in other tissues [3,12-141. 
Following on from the recent identification of gliben- 
clamide as a potent inhibitor of the CFTR Cl- channel 
[4] we have, in this study, tested the effect of gliben- 
clamide, meglitinide and tolbutamide on the transport 
of a variety of low molecular weight solutes into ma- 
laria-infected cells and on the in vitro growth of the 
malaria parasite. The results have implications not only 
for the possible identity and chemotherapeutic potential 
of the malaria-induced pathways. but also for the use 
of glibenclamide and its analogues as tools for the diag- 
nosis of K’-ATP channel involvement in physiological 
processes. 
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2. MATERIALS AND METHODS 
2.1 Materials 
[YJCholine Cl and Na’hC1 were from Amersham International. 
Plasmagel was a gift from Laboratolre Roger Bellon, Neuilly sur 
Seme. France. The sulfonyl ureas and 4.4’-dlisothiocyanatostllbene- 
2,2’-disulfomc acid (DIDS) were from Sigma. 5-Nltro-2-(3-phenylpro- 
pylammo)benzolc acid (NPPB) was a generous gift from Prof. R. 
Greger (Physiologisches Institut der Albert-Ludwigs-Umversitat. 
Freiburg, Germany). The chemical structures of ghbenclamide. meg- 
litinide and tolbutamlde are shown in Fig. 1. 
2.2. Cell culture 
Human erythrocytes (type 0) infected with the IT04 line of Plc~v~~o- 
dizun fulciparum [15] were cultured under 1% 0:. 3% CO,. 96% N, in 
RPM1 1640 culture medium (Glbco. Glasgow. UK) supplemented 
with HEPES (40 mM), glucose (10 mM), glutamme (2 mM). gentam- 
icin sulphate (25 mg/l) and serum (10% v/v. pooled from different 
donors, Blood Transfusion Service, Oxford and Bristol). All experl- 
ments were carried out using synchromsed suspensions of trophozoite- 
infected cells (approximately 35 h post-invasion, 40@90% parasi- 
taemia). prepared usmg a combination of sorbitol haemolysis [16] and 
gelatm (Plasmagel) flotation [I 71 as described elsewhere [I 81. 
Cell concentrations were determined using either a Coulter counter 
(Model Zm) or an improved Neubauer counting chamber Parasl- 
taemia was estimated from methanol-fixed Glemsa-stained smears. In 
experiments comparmg uninfected cells with malaria-infected mate- 
rial, erythrocytes (from the same donor) were incubated m parallel 
with the infected red cell cultures under ldentlcal condltlons for at least 
24 h prior to the experiment. 
The enhanced permeability of the malana-infected erythrocyte 
membrane to the sugar alcohol, D-sorbitol. and the amino acid. L- 
threonme. was studied using a simple haemolysis method 1191. Iso- 
osmotic solutions of sorbitol and threonme were prepared by dissolv- 
ing the compounds to a concentration of 300 mM in H,O containing 
10 mM HEPES (pH 7.4). Haemolysis time courses mere commenced 
by the addition of malaria-infected cells (suspended at a haematocrit 
of approximately 10% m normal growth medium) to the different 
solutions of interest (pre-warmed to 37°C) to give a final haematocrlt 
of approximately 0.5% Aliquots of the suspension were sampled at 
regular intervals into mlcrocentrlfuge tubes containing Ice-cold, hy- 
pertonic sucrose solution (400 mM. 0 5 ml). The tubes were centri- 
fuged (10.000 x g. 15 s) and the amount of haemoglobm m the super- 
natant solution (and hence the degree of haemolysis) has estimated 
from the absorbance at 540 nm. 
Normal uninfected erythrocytes remained stable m the Iso-osmotic 
solutions for the period of the experiments (30--60 mm). Haemolysla 
may therefore be attributed to the net influx of the compounds into 
the infected cells via the malaria-Induced transport pathways. 
2.4. CI @u.r mcusuremetlt.~ 
Time courses for Cl- influx were measured at room temperature m 
cells washed ( x 4) m HEPES-buffered. serum-free sahne (125 mM 
NaCI. 5 mM KCI, 25 mM HEPES, 5 mM glucose) then treated with 
DIDS, a potent inhibitor of the band 3 anion exchanger. For each time 
course 6 microcentrifuge tubes were prepared, each containing a lower 
oil phase of 0.2 ml of dlbutyl phthalate and an upper aqueous phase 
of 0.15 ml of saline which contamed DIDS (l0,~M). ‘“Cl- (0.6pCllml) 
and. where appropriate. ghbenclamide, meglitinide or tolbutanude At 
predetermmed intervals, an ahquot of cell suspension (0. I5 ml. prein- 
cubated for 10 mm at room temperature with 10 PM DIDS) was 
dispensed into each tube m turn to give a final cell concentration of 
around 1 x IO’ cells/ml. Immediately followmg the addition of cells to 
the final tube in the series the samples were centrifuged (10,000 x K. 
30 s) to sediment the cells below the 011 and thereby terminate the flux. 
The time taken between starting the centrifuge and termmatlon of the 
flux was taken as 2 s [20]. Following sedimentation of the cells below 
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the oii. the aqueous supernatant solution was removed by aspiration 
then the radioactivity remaining on the walls of the tube was removed 
by rinsing the tubes four times with water. The dibutyl phthalate was 
aspirated then the cell pellet was lysed pith 0.1% (v/v) Triton X-100 
(0.5 ml) and deproteimsed by the addltlon of 5% w/v trlchloroacetlc 
acid (0.5 ml). followed by centrifugation (10.000 x K, 10 mm). The 
amount of radIolabel was measured using a j&cmtillation counter. 
The amount of radiolabel trapped in the extracellular space within 
the cell pellets was estimated from Ice-cold samples containing NPPB 
(0.1 mM, [S]) which were centrifuged Immediately following the addl- 
tion of DIDS-treated cell suspension (0.15 ml) to the ‘W solution 
(0.15 ml) 
The umdirectlonal Influx of chohne into erythrocytes at 37°C was 
estimated from the uptake of [‘JC]chohne during a short (5 mm) 
incubation period that fell withm the mltlal, approximately hnear 
portion of the [‘JC]cholme influx tmle course. Unless specified other- 
wise, infected cells were washed four times m HEPES-buffered serum- 
free saline (125 mM NaCI, 5 mM KCI. 15 mM HEPES. 5 mM glucose) 
at 37”C, then resuspended and combined with the appropriate reagent 
solutions m microcentrlfuge tubes. The tubes were transferred to a 
37°C hater bath and allowed at least IO mm to temperature-equih- 
brate. Fluxes were started by the addition of [‘“C]chohne. together 
with unlabelled substrate to give a final actlvlty of I &Yrnl-’ and a 
final extracellular choline concentration of I mM The final sample 
volume was 0.5 ml and the final cell concentration wab typIcally 2 x 10” 
RBCm-’ 
Choline Influx was termmated by transferring aliquots (0.11 ml) of 
the suspension to mlcrocentrlfuge tubes contaming 0.8 ml of ice-cold 
‘stoppmg solution’ (isotonic sahne supplemented with 0 1 mM fu- 
rosemide; [S]) layered over 0 25 ml of dlbutyl phthalate. The tubes 
were centrifuged immrdlately (10.000 x g, 30 s) to sediment the cells 
below the 011, then the supernatant solution has removed by aspiration 
and the samples processed for p-scmtlllatlon countmg as descrtbed 
above. 
The amount of[‘JC]choline trapped m the extracellular space withm 
the cell pellets was estimated from ahquots (0.1 I ml) taken from 
samplea containing the transport inhibitors ldenttfied m this study. 
immediately followmg the addition of radlolabel. These were trans- 
ferred to stopping solutions (0.8 ml) layered over dlbutyl phthalate 
(0.25 ml) and processed as described above. 
In experiment5 to test the revcrslbihty of the effect of glibenclamide 
on choline Influx, cells m HEPES-buffered saline were Incubated in the 
presence or absence of the inhIbItor for 10 mm then washed ( x 3) by 
repeated centrifugation and resuspension in HEPES-buffered. In ex- 
periments to teat the effect of serum (10% v/v) on ghbenclamlde- 
inhIbItion cells were washed ( x 4) in RPM1 then resuspended in the 
same solution m the presence or absence of serum (10% v/v) Gliben- 
clamlde was added at a concentration of 0.1 mM and the samples were 
Incubated for 10 min at 37°C before measuring chohne influx. 
2.6. In ~~lfro groti’th LI.Y.WJ~S 
The antimalarial activity of glibenclamide. meghtmlde and tolbu- 
tamlde Nas tested usmg [‘Hlhypoxanthme mcorporatlon as a marker 
for parasite growth [21,22]. Serial dilutions of the mhibltors in DMSO 
(0.4~1) were dispensed into 96-well culture plates, to which were then 
added tightly synchronised cultures of rmg-stags Infected erythrocytes 
(200~1 at 2% haematocrit and l-39 parasltaemla in growth medium). 
[‘Hlhypoxanthlne was added at an actlvlty of 2.5 ,&llml (spec. act. 5 
mCi/mmol) The plates were mamtained m a gas-tight box at 37’C for 
18-24 h so that labelling occurred within a single cycle of maturation. 
then harvested using an LKB harvester. A flat-bed Betaplate scmtllla- 
tion system wab used to measure incorporated radIoactIvIty [22]. 
3. RESULTS 
The effect of glibenclamide, meglitinide and tolbu- 
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Fig. 1. Chemical structures of ghbenclamtde, meghtmide and tolbu- 
tamide. Tolbutamtde consists of much of the sulfonyl urea portion of 
ghbenclamide, while meglitmide is equtvalent to the non-sulfonyl urea 
portion of the molecule. 
tamide on the transport of the sugar alcohol D-sorbitol 
and the amino acid L-threonine into malaria-infected 
cells is illustrated in Fig. 2. Glibenclamide (0.1 mM) 
caused a dramatic decrease in the rate of haemolysis in 
both the sorbitol and threonine solutions, consistent 
with it having blocked the influx of both compounds 
into the infected cells. Meglitinide (0.1 mM) was less 
effective at slowing haemolysis in the two solutions, 
while tolbutamide (0.1 mM) was without significant ef- 
fect. 
Fig. 3 shows time courses for the transport of Cl- into 
infected and uninfected cells. In uninfected erythro- 
cytes, pretreated with 10 ,uM DIDS there was negligible 
uptake of Cl- over 21 s. In contrast, Cl- was transported 
rapidly into DIDS-treated infected cells and equili- 
brated within a few seconds. The influx of Cl- into 
infected cells was slowed by glibenclamide (0.5 mM) 
and, to a lesser extent, by meglitinide (0.5 mM). Tolbu- 
tamide (0.5 mM) had little effect. 
The inhibitory properties of glibenclamide, megliti- 
nide and tolbutamide were investigated in more detail 
using the monovalent organic cation choline as a test 
substrate. Choline is transported into normal human 
erythrocytes via a saturable carrier with a Km of around 
10 ,uM [23,24]. Transport of choline via the malaria- 
induced pathways is non-saturable [25-271 and in the 
experiments reported here choline was therefore pre- 
sented at an extracellular concentration of 1 mM in 
order to saturate and thereby minimise the relative con- 
tribution of the native transporter to the total influx. 
Under these conditions the unidirectional influx of 
choline measured in trophozoite-infected cell suspen- 
sions (45-85% parasitaemia, II = 8) was 117 +_ 15 
( + S.E.M.) pmoll(10’2 RBC.h), compared with a value 
of 4.2 ? 0.5 pmoll( 10’” RBC.h) in uninfected cells from 
the same donors; in almost all experiments over 95% of 
the choline influx measured in infected cell suspensions 
was parasite-induced. 
Glibenclamide, meglitinide and tolbutamide inhibited 
the influx of choline into malaria-infected erythrocytes 
with the same rank order of potency as that seen for the 
other substrates tested. Dose-response curves are shown 
in Fig. 4A. The IC,, values for glibenclamide, megliti- 
nide and tolbutamide (i.e. the concentrations at which 
the inhibitory effects were half maximal) were 11 + 2, 
52 + 6 and > 500 PM, respectively (n = 4). The inhibi- 
sorbitol threonine 
_!L 
0 15 30 0 30 60 
-. / . \ 
I Ime (min) 
Fig. 2. Time courses for haemolysis of malaria-Infected erythrocytes suspended in iso-osmottc solutions of sorbitol and threonine m the absence 
(8:)) or presence of ghbenclamide (0.1 mM, l ), meglitinide (0.1 mM, H) or tolbutamide (0.1 mM, A). The data were averaged from three different 
experiments using cells from different donors and are shown f S.E.M. In similar experiments with normal uninfected erythrocytes the cells remained 
stable in the iso-osmotic solutions for 2 1 h. Haemolysis of Infected cells may therefore be attrtbuted to parastte-Induced modification of the host 
cells. 
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Fig. 3. Time courses for influx of Cl- in uninfected erythrocytes (-4 
and in a synchronised trophozoite-Infected cell suspension (84% para- 
sltaema). either in the absence of Induced transport mhlbitors (1. ) or 
in the presence of glibenclamide (0 5 mM, l ), meghtmide (0.5 mM, 
n ) or tolbutamide (0.5 mM, A). All samples contained 1OflM DIDS. 
The data is from one of two similar expernnents on cells from different 
donors. 
tion of malaria-induced choline transport by gliben- 
clamide was fully reversible: when infected cells were 
preincubated for IO min with glibenclamide then 
washed (x 3) by centrifugation and resuspended in 
glibenclamide-free saline the choline flux was the same 
as that in cells not previously exposed to the inhibitor 
(Fig. 4B). Glibenclamide inhibition was attenuated by 
the presence of serum (10% v/v) in the extracellular 
medium, which would suggest that serum components 
compete with the transport pathways for binding the 
inhibitor (Fig. 4B). 
If, as has been postulated [28,29], the malaria-induced 
permeation pathways play an important role in the de- 
velopment of the intracellular parasite it might be ex- 
pected that the transport inhibitors identified here 
should inhibit parasite growth. We therefore tested the 
effect of the three compounds of interest on the incorpo- 
ration of [~Hlhypoxanthine by the parasite over an 18- 
24 h period (commencing with cells synchronised at the 
ring stage of maturation). In our initial growth assays 
in which cells were grown in the presence of 10% v/v 
human serum the inhibitors were without significant 
effect. However, when the serum concentration was re- 
duced to 2% (the minimum required to support parasite 
growth in the short term) glibenclamide and megliti- 
nide, but not tolbutamide, were found to inhibit [“H]hy- 
poxanthine incorporation (Fig. 5). The ICio value for 
glibenclamide was 39 +- 6 ( 2 S.E.M., FZ = 3) ,f.&4 while 
that of meglitinide was approximately 5-fold higher. 
4. DISCUSSION 
In this study we tested the effect of glibenclamide, 
meglitinide and tolbutamide on the transport of a sugar 
alcohol. an amino acid, an inorganic anion and an or- 
ganic cation via the permeation pathways that are in- 
duced in human erythrocytes following malaria infec- 
tion. While not as potent as some of the transport inhib- 
itors identified previously [8] glibenclamide and megliti- 
nide were found to block the malaria-ind~I~ed transport 
of all of the substrates tested, and in each case the 
relative inhibitory potency of the three reagents was the 
same - glibenclamicle 2 meglitinide >> tolbutamide. 
This is, to our knowledge, the first demonstration of the 
inhibition by these widely used compounds of the trans- 
port of organic substrates. The data are consistent with 
the view that a diverse range of solutes enter infected 
cells via common pathways. Furthermore, they provide 
additional support for the hypothesis that these path- 
ways have features in common with anion-selective 
channels in other cells. The sulfonyl ureas are best 
known as inhibitors of K’-ATP channels and are not 
widely recognised as Cl- channel blockers. However, 
glibenclamide inhibits Cl- conductance in the mammal- 
ian kidney [3] and has recently been identified as an 
-I 
0.1 1 10 100 1000 
[Inhibitor] (,uM) 
Fig. 4. (A) Dose--response curves for the effects of ghbenclamide (0). meglitinide (m) and tolbutamide (A) on influx of chohne into malaria-infected 
erythrocytes. (B) Reverslblhty (solid bars) and effect of serum (10% v/v; cross-hatched bars) on ghbenclamIde-inhlbition of choline Influx mto 
malaria-infected erythrocytes. The extracellular chohne concentration was 1 mM. Choline influx m the presence of mhibltor (or m cells exposed 
previously to Inhibitor) is expressed as a percentage of that measured m cells treated in a similar manner in the absence of mhibltor. The data were 
averaged from at least three different experiments usmg cells from different donors and are shown + S.E.M. 
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Fig. 5. Dose-response curves for the effects of ghbenclamide. megli- 
timde and tolbutamlde on mcorporation of [‘Hlhypoxanthme by ma- 
laria parasites over a I8 h period, commencing with sorbitol-syn- 
chromsed ring-stage cultures. The growth medium contained 3% v/v 
serum. The data are from a angle representative experiment; each 
pomt represents the average [‘Hlhypoxanthme incorporation mea- 
sured m 7 rephcate wells of a 96-well plate. Standard deviations fell. 
in most cases, within the symbols and are not shown. 
effective inhibitor of CFTR, the cystic fibrosis Cl- chan- 
nel [4]. The IC,, found here for the inhibition by gliben- 
clamide of malaria-induced choline transport (11 PM) 
is very similar to that reported for CFTR (-20 PM); 
however glibenclamide inhibition of the malaria-in- 
duced pathway was readily reversible (Fig. 4B) whereas 
that of CFTR was reportedly not [4]. The pathways also 
differ somewhat in their susceptibility to tolbutamide 
which blocks CFTR with an IC,, of around 150 PM [4] 
but which has little effect on the malaria-induced path- 
ways at concentrations below 500 PM. The effect of 
meglitinide on the CFTR channel has not. to our 
knowledge, been reported. 
Glibenclamide is the most potent inhibitor of the 
CFTR channel that has been identified to date. The 
same is not true of the malaria-induced pathway which 
is blocked by NPPB at sub-micromolar concentrations. 
NPPB does block CFTR, though relatively high con- 
centrations are required [30]. The pharmacological sim- 
ilarities between CFTR and the malaria-induced path- 
ways are therefore more qualitative than quantitative, 
which makes it seem unlikely that CFTR itself is re- 
sponsible for the enhanced permeability of infected 
cells. Perhaps more likely is the possibility that the in- 
duced transport is mediated by a related protein, con- 
ceivably another member of the ABC (ATP binding 
cassette) superfamily. This is a large group of mem- 
brane proteins which show a varying degree of homol- 
ogy and which include numerous bacterial active trans- 
port systems, the human multidrug resistance pump, 
P-glycoprotein [31], and the products of the P. fukipa- 
rum genespfmhl andpfmdr2 [32,33]. In bacteria, mem- 
bers of this family are involved in the import of a wide 
variety of nutrients, whereas in eukaryotes they nor- 
mally perform an export function [31]. Of the family 
members identified to date, only CFTR has been shown 
conclusively to function as a chloride channel; however 
recent evidence suggests that the same may be true of 
P-glycoprotein [34,35]. Whether other members of the 
family might also function as anion-selective channels, 
with properties similar to CFTR, remains an open ques- 
tion. 
The rank order of potencies of the three inhibitors 
tested here on the malaria-induced pathways (gliben- 
clamide > meglitinide > tolbutamide) is the same as that 
for the inhibition of K’-ATP channels [l]. The IC,, 
values for inhibition of malaria-induced choline influx 
are much higher than those for K’-ATP channels in 
/I-cells [I] but they are within an order of magnitude of 
those for K’-ATP channels in muscle [2]. Quite apart 
from the question of whether this might reflect struc- 
tural similarities between the parasite-induced path- 
ways and K+-ATP channels (as has been suggested for 
CFTR; [36]), this has obvious implications for the use 
of glibenclamide and its analogues as tools for the diag- 
nosis of K’-ATP channel involvement in physiological 
processes. Amongst cation-selective channels gliben- 
clamide and its various analogues are apparently fairly 
specific for K’-ATP channels (reviewed in [37]); how- 
ever, the malaria-induced pathways, although anion- 
selective, have a significant permeability to cations, in- 
cluding K+(“Rb+) [18]. Whatever their identity, path- 
ways of this sort should therefore be considered before 
sulfonyl urea-sensitive K’ transport may be attributed 
unambiguously to K’-ATP channels. 
In the in vitro growth assays. parasites grown in me- 
dium containing 10% serum were almost unaffected by 
the three inhibitors of interest. However, when the 
serum concentration was reduced to 2% v/v, [3H]hy- 
poxanthine incorporation was inhibited by gliben- 
clamide (IC,, = 39 ,uM) and, with lesser potency, 
meglitinide (Fig. 5). Tolbutamide had no effect, at con- 
centrations up to 0.5 mM. The relative effects of gliben- 
clamide, meglitinide and tolbutamide on [3H]hypoxan- 
thine incorporation were therefore the same as those for 
their inhibitory effects on the induced transport path- 
ways. This is consistent with the induced pathways 
being the site of action for the antimalarial activity of 
these drugs. The IC,, values for inhibition by gliben- 
clamide and meglitinide of parasite growth were some- 
what higher than those for the inhibition of induced 
transport which was measured in cells exposed for short 
times in serum-free solution. However, these differences 
can be accounted for by binding of the inhibitors to 
serum components as it is clear from Fig. 4B that the 
presence of serum alleviates inhibition of the induced 
transport pathways. If inhibitors such as these are to be 
of chemotherapeutic value the challenge will be to iden- 
tify reagents that will bind preferentially to the induced 
transport pathways in the presence of serum. 
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